Collaborative Care for Depression and Diabetic Retinopathy in African Americans

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02121340
• Date of registration: 21/04/2014
• Prospective Registration: Yes
• Primary sponsor: Thomas Jefferson University
• Public title: Collaborative Care for Depression and Diabetic Retinopathy in African Americans CC-DDR
• Scientific title: Collaborative Care for Depression and Diabetic Retinopathy in African Americans
• Date of first enrolment: May 2014
• Target sample size: 40
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02121340
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
• Phase: N/A

Countries of recruitment

United States

Contacts

• Name: Robin Casten, PhD
• Affiliation: Thomas Jefferson University

• Name: Barry Rovner, MD
• Affiliation: Thomas Jefferson University

Key inclusion & exclusion criteria

Inclusion Criteria:

1. African-American race

2. age = 65 years

3. type 2 diabetes

4. mild or moderate nonproliferative DR with or without macular edema

5. depressive symptoms (i.e., Patient Health Questionnaire-9 score =5)

6. HbA1C = 7.0%

Exclusion Criteria:

1. treated proliferative DR

2. global cognitive impairment (i.e., Mini Mental Status score = 20)

3. psychiatric diagnosis other than depression

4. treatment for depression started in the previous 3 months

5. life expectancy under 2 years



Age minimum: 65 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Diabetic Retinopathy

Intervention(s)

Behavioral: Behavioral Activation

Primary Outcome(s)

Hemoglobin A1c [Time Frame: 12 months]

Secondary ID(s)

R34EY024299

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Wills Eye